Global Custom Market Research Reports Provider Company

phone

Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review

  • Published Date: 01 Feb 2015
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: United States of America

Summary

Esperion Therapeutics, Inc. (Esperion) is a biotechnology company. The company develops and commercializes oral, small molecule therapies for the treatment of patients with low-density lipoprotein cholesterol and other cardiometabolic risk factors. Esperion’s products include ETC-1002, ESP41091, 4WF, and HDL Mimetics. Its ETC-1002 is an oral drug for patients who have/are at risk for developing, cardiovascular and metabolic diseases. The company’s second generation compounds impacts lipid and carbohydrate metabolism and inflammation; and HDL mimetic therapies are designed to rapidly eliminate cholesterol and other lipids from the arterial wall and related tissues. The company operates as a subsidiary of Pfizer Inc. Esperion is headquartered in Plymouth, Michigan, the US.

Esperion Therapeutics, Inc. Key Recent Developments

Dec 23, 2013: Esperion Therapeutics Added to the NASDAQ Biotechnology Index
Nov 06, 2013: Esperion Therapeutics Reports Third Quarter 2013 Financial Results
Nov 05, 2013: Esperion Therapeutics to Present at Credit Suisse Healthcare Conference
Sep 24, 2013: Esperion Therapeutics to Present at BioCentury Newsmakers in the Biotech Industry Conference
Sep 10, 2013: Esperion Therapeutics to Present at Stifel Nicolaus 2013 Healthcare Conference

This comprehensive SWOT profile of Esperion Therapeutics, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Esperion Therapeutics, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief Summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Publisher Name : GlobalData


Section 1 - About the Company

Esperion Therapeutics, Inc. - Key Information
Esperion Therapeutics, Inc. - Overview
Esperion Therapeutics, Inc. - Key Employees
Esperion Therapeutics, Inc. - Key Employee Biographies
Esperion Therapeutics, Inc. - Key Operational Heads
Esperion Therapeutics, Inc. - Major Products and Services
Esperion Therapeutics, Inc. - History
Esperion Therapeutics, Inc. - Company Statement
Esperion Therapeutics, Inc. - Locations And Subsidiaries
Esperion Therapeutics, Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Esperion Therapeutics, Inc. - Business Description
Esperion Therapeutics, Inc. - Corporate Strategy
Esperion Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Esperion Therapeutics, Inc. - Strengths
Esperion Therapeutics, Inc. - Weaknesses
Esperion Therapeutics, Inc. - Opportunities
Esperion Therapeutics, Inc. - Threats
Esperion Therapeutics, Inc. - Key Competitors

Section 3 - Company Financial Performance Charts

Esperion Therapeutics, Inc. - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company



List Of Tables


Esperion Therapeutics, Inc., Key Information
Esperion Therapeutics, Inc., Key Ratios
Esperion Therapeutics, Inc., Share Data
Esperion Therapeutics, Inc., Major Products and Services
Esperion Therapeutics, Inc., History
Esperion Therapeutics, Inc., Key Employees
Esperion Therapeutics, Inc., Key Employee Biographies
Esperion Therapeutics, Inc., Key Operational Heads
Esperion Therapeutics, Inc., Other Locations
Esperion Therapeutics, Inc., Subsidiaries
Esperion Therapeutics, Inc., Key Manufacturing facilities
Esperion Therapeutics, Inc., Key Competitors
Esperion Therapeutics, Inc., SWOT Analysis
Esperion Therapeutics, Inc., Ratios based on current share price
Esperion Therapeutics, Inc., Annual Ratios
Esperion Therapeutics, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios



List Of Figures


Esperion Therapeutics, Inc., Performance Chart
Esperion Therapeutics, Inc., Ratio Charts



Esperion Therapeutics Inc (Esperion) is a pharmaceutical company that develops and commercializes oral therapies to treat patients with elevated low-density lipoprotein cholesterol (LDL-C). The companys lead product candidate, Bempedoic acid,

View Report

Esperion Therapeutics, Inc. (ESPR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile market research report at USD 250 and market update available at JSB Market Research.

View Report

Esperion Therapeutics, Inc. (ESPR) - Financial and Strategic SWOT Analysis Review market research report at USD 300 and market update available at JSB Market Research.

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports